Bookmark

Add to MyYahoo RSS

Excaliard Pharmaceuticals News

News on Excaliard Pharmaceuticals (Ticker: PFE) continually updated from thousands of sources around the net.

23 hrs ago | The San Diego Union-Tribune

Epic Sciences raises $30 million

Epic Sciences , a spinoff of The Scripps Research Institute developing cancer diagnostics, has raised $30 million from venture capital investors, and appointed Greg Lucier as board chairman.

Comment?

Related Topix: Scripps Research Institute, Technical Services, Venture Capital, Emerging Technology, Cell Biology, Biology, Science

Yesterday | Freshnews

Pfizer Enters Into Agreement to Acquire Baxter's Portfolio of Marketed Vaccines

Pfizer Inc. today announced that it has entered into a definitive agreement to acquire Baxter International Inc.'s portfolio of marketed vaccines for $635 million.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Baxter International, E.Factor

Yesterday | Forbes.com

Puma Biotech's Overnight Billionaire On One Of His Keys To Success

Alan Auerbach hit the jackpot when stock of Puma Biotechnology, the drug company he founded, skyrocketed 295% on July 23 following good news from a Phase III clinical trial of an experimental breast cancer drug that Puma licensed from Pfizer.

Comment?

Related Topix: Biotech, Science / Technology, Healthcare Law, Law, Medicine, Health, Breast Cancer, Pfizer, Foldrx Pharmaceuticals

Tue Jul 29, 2014

Customer Interaction Solutions

Pfizer Reports Second-Quarter 2014 Results

Pfizer Inc. reported financial results for second-quarter 2014. At the beginning of fiscal year 2014, the company began managing its commercial operations through a new global commercial structure consisting of three operating segments: the Global Innovative Pharmaceutical segment ; the Global Vaccines, Oncology and Consumer Healthcare segment ; ... (more)

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Centers for Disease Control and Prevention

Investor's Business Daily

Merck, Pfizer Beat Q2 Earnings Estimates

Merck stock was up more than 1%, while Pfizer stock was up a fraction in early trading on the stock market today .

Comment?

Related Topix: Pfizer, Biotech, Merck , Medicine, Healthcare Industry, Foldrx Pharmaceuticals

TheStreet.com

U.S. Stocks Higher as Merck, Pfizer Top Expectations

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Financial Markets, Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Mozilla

TheStreet.com

Stock Market Today: U.S. Stocks Higher as Merck, Pfizer Top Expectations

NEW YORK -- Major U.S. stock markets opened higher on Wall Street Tuesday as investors were greeted by upbeat earnings reports and policymakers commenced with the first day of the Federal Open Market Committee meeting.

Comment?

Related Topix: TheStreetcom, Media, TheStreet, Computers, Financial Markets, Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals

KAUZ

Pfizer's 2Q profit sinks 79 pct but tops forecasts

Most of the 1,200 people driven to evacuate by a Northern California wildfire that destroyed 13 homes have been told they can safely return after a series of steady gains in the firefight.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Natural Disasters, Wildfire, Fire

Silver City Sun-News

Pfizer's 2Q profit sinks 79 pct but tops forecasts

Pfizer's second-quarter earnings plunged 79 percent from last year, when the world's second-largest drugmaker booked a business spinoff gain of more than $10 billion, but results in the most recent quarter still edged analyst expectations.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Collinsville, IL

Mon Jul 28, 2014

Seeking Alpha

Whisper Number Impact: How Will Pfizer's Stock Move After Earnings?

Pfizer has a 59% positive surprise history . The overall average post earnings price move is 'positive' when the company reports earnings.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals

Forbes.com

Interesting November Stock Options for Pfizer

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc .

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Financial Markets

Seeking Alpha

Why Pfizer Will Trade At $40 On Improved Drug Pipeline

Pfizer is trading at a P/E that is almost 30 points below Merck , 13 points below Novartis and 15 point below Sanofi .

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Merck , Novartis

Sun Jul 27, 2014

Benzinga

Earnings Expectations For The Week Of July 28: Exxon, Pfizer, Twitter And Much More

The earnings crunch continues, and reports so far have generally been encouraging.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Exxon Mobil, Energy, Oil & Gas, ExxonMobil Chemical, Chemicals

Sat Jul 26, 2014

Benzinga

Weekly Preview: FOMC In Focus, As Earnings Season Progresses

The US Federal Open Market Committee is set to have a two-day policy meeting next week against a backdrop of geopolitical tension and the US earnings season.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Exxon Mobil, Energy, Oil & Gas, ExxonMobil Chemical, Chemicals

Thu Jul 24, 2014

Daily Kos

Obama: Companies "cherry-picking the rules, and it damages the country's finances"

I detect a president who thinks he's found a very potent political argument. Having gone soft on the bankers, letting all the big fish skate after wrecking the economy, the president has figured out that people just won't stand for a tax system that leaves regular people holding the tab while CEOs figure out how to screw the public, day after day.

Comment?

Related Topix: US Politics, US News, US Senate, Carl Levin, Democrat, Liberal Political News

Seeking Alpha

Did Pfizer Make A Horrible Business Deal?

Pursuant to the recent amendment, Pfizer will be due a lower royalty rate in exchange for not funding the upcoming trials.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Science / Technology, Oncology

Wed Jul 23, 2014

Seeking Alpha

Today's Market: Biotech Names Rallying Today

Our regular readers know that we have been using the idea of buying on the dips and searching for value while investing in this bull market the past few years.

Comment?

Related Topix: Biotech, Science / Technology, Medicine, Pfizer, Healthcare Industry, Foldrx Pharmaceuticals

Mon Jul 21, 2014

Forbes.com

One Put, One Call Option To Know About for Pfizer

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc .

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Financial Markets

BioSpace

Candid Advice For Cash-Strapped Startups From A Biotech VC

July 21, 2014 By Josh Baxt , BioSpace.com Exclusive Story In a sense, Niall O'Donnell, Ph.D., and his colleagues at RiverVest Venture Partners run a biomedical adoption agency.

Comment?

Related Topix: Venture Capital, Emerging Technology, Startups, BioSpace.com, Oncology, Medicine

Thu Jul 17, 2014

BioSpace

Bristol-Myers Squibb Company And Pfizer Inc. Announce Enrollment Of...

Bristol-Myers Squibb Company And Pfizer Inc. Announce Enrollment Of First Patient In Phase IV EMANATE Trial To Assess Effectiveness And Safety Of Eliquis In Patients With NVAF Undergoing Cardioversion PRINCETON, N.J. & NEW YORK-- --Bristol-Myers Squibb Company and Pfizer Inc. today announced that the first patient has been enrolled into a Phase IV ... (more)

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Pfizer, Princeton, NJ, Bloomsbury Publishing, Publishing, Media, Medarex

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••